Elevation Oncology Inc. (ELEV)

0.52

0.00 (0.95%)

At close: Feb 28, 2025, 3:59 PM

0.58

9.85%

Pre-market: Mar 03, 2025, 05:03 AM EST

Elevation Oncology Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Net Income	-45.7M	-95.08M	-32.04M	-17.27M	-5.88M
Depreciation & Amortization	39K	27K	18K	15K	n/a
Stock-Based Compensation	3.33M	3.21M	1.57M	52K	13.5K
Other Working Capital	-7.83M	5.58M	313K	-319K	-37K
Other Non-Cash Items	-160K	74K	1.64M	-5.14M	-451K
Deferred Income Tax	n/a	n/a	-1.64M	5.14M	n/a
Change in Working Capital	-13.69M	6.29M	283K	4.9M	423K
Operating Cash Flow	-56.18M	-85.48M	-30.17M	-12.3M	-5.45M
Capital Expenditures	n/a	-86K	n/a	-71K	n/a
Acquisitions	n/a	44.31K	n/a	n/a	n/a
Purchase of Investments	-42.66M	-112.31M	n/a	n/a	n/a
Sales Maturities Of Investments	54.2M	68M	n/a	n/a	n/a
Other Investing Acitivies	n/a	-44.31K	n/a	n/a	n/a
Investing Cash Flow	11.54M	-44.4M	n/a	-71K	n/a
Debt Repayment	n/a	30M	n/a	n/a	n/a
Common Stock Repurchased	-24K	-35K	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	1.5M	-451K	-11K	90.01M	10.79M
Financial Cash Flow	47.98M	29.51M	97.05M	90.03M	7.19M
Net Cash Flow	3.34M	-100.37M	66.88M	77.66M	1.74M
Free Cash Flow	-56.18M	-85.57M	-30.17M	-12.37M	-5.45M